microdosing glp 1 menopause What Is GLP-1? Full Guide Microdosing GLP‑1 in Menopause &

Description

Distinct from prior reviews that predominantly focus on a single drug class or limited clinical indications, this article systematically contrasts the mechanistic pathways, therapeutic efficacy, and safety profiles of GLP-1RAs versus GLP-1/GIP dual receptor agonists

But "better in a trial" and "better for your specific body" are two very different things

In this context, the aim of the present document is to summarize, in the form of a narrative literature review, the currently available data on the main mechanisms of action of GIP/GLP-1 co-agonists and the clinical effects of tirzepatide evaluated in various clinical trials

However, BMI remained unchanged, indicating that the intracranial pressure effect was likely a direct action of exenatide rather than weight loss alone